ResoundingHealth
Search
  
Basic Drug Info
Drug Name:Didanosine
Manufacturer:Aurobindo Pharma USA, Inc.
Other Info:

Didanosine delayed-release capsules are not a cure for HIV-1 infection, and patients may continue to develop HIV-associated illnesses, including opportunistic infection.

Therefore, patients should remain under the care of a physician when using didanosine delayed-release capsules.

Patients should be advised that didanosine delayed-release capsules therapy has not been shown to reduce the risk of transmission of HIV to others through sexual contact or blood contamination.

Patients should be informed that the long-term effects of didanosine delayed-release capsulesare unknown at this time.


Clinical Trials:

Indications and Usage
Didanosine delayed-release capsules, known as ddI, in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 infection [see Clinical Studies (14)].
HIV Infections -- any state of infection accompanied by evidence of HIV in the body (positive test for HIV genome, cDNA, proteins, antigens, or antibodies); may be medically asymptomatic or symptomatic; use AIDS when appropriate.

Contraindications
None.
Branded Drugs
The following US Branded drugs contain Didanosine

VIDEX EC -- BRISTOL MYERS SQUIBB CO

VIDEX -- BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE


This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor. It should not to be used for self-diagnosis or treatment.